IMV Inc. (IMV) Names Kyle Kuvalanka to Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
IMV Appoints Kyle Kuvalanka to Board of Directors
March 25, 2021 7:05 AM EDTIMV to leverage Mr. Kuvalankas industry expertise as it advances its lead immunotherapy toward potential registration and commercialization
Company advancing novel immunotherapies in oncology and infectious diseases built on its proprietary DPX platform with novel lipid-based delivery technology
Wayne Pisano to retire after 10 years as a Board member
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)-- IMV Inc. (the "Company" or "IMV") (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced the... More
